JOINT FILING AGREEMENT

Exhibit 1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all additional amendments thereto) with respect to the ordinary shares of China Biologic Products Holdings, Inc. and further agree that this joint filing agreement (this “Agreement”) shall be included as an Exhibit to such joint filing. Each person further agrees as follows:

1. Each person executing this Agreement is responsible for the timely filing of such Schedule 13D and any subsequent amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but no person executing this Agreement is responsible for the completeness or accuracy of the information concerning any other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

2. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which, taken together, shall constitute one and the same instrument.

[Remainder of Page Intentionally Left Blank]

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of April 8, 2020.

	2019B CAYMAN LIMITED
	By:		/s/ Xxxxxx Xxxxxxxxx
			Name:		Xxxxxx Xxxxxxxxx
			Title:		Director
	CITIC Capital China Partners IV, L.P.
	By: CCP IV GP LTD., its General Partner
	By:		/s/ Xxxx Xxx Kong
			Name:		Xxxx Xxx Kong
			Title:		Director
	CCP IV GP LTD.
	By:		/s/ Xxxx Xxx Kong
			Name:		Xxxx Xxx Kong
			Title:		Director
	CITIC CAPITAL PARTNERS LIMITED
	By:		/s/ Xxxx Xxx Kong
			Name:		Xxxx Xxx Kong
			Title:		Director
	CITIC CAPITAL HOLDINGS LIMITED
	By:		/s/ Xxxxxx Xxxxx
			Name:		Xxxxxx Xxxxx
			Title:		Director

[Signature page to Schedule 13D Joint Filing Agreement]